Radical radiotherapy for urinary bladder cancer: treatment outcomes
暂无分享,去创建一个
[1] L. Sengeløv,et al. Chemotherapy in Locally Advanced and Metastatic Bladder Cancer , 2005 .
[2] H. von der Maase,et al. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] H. von der Maase,et al. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer , 2004, Acta oncologica.
[4] Y. Sumiyoshi. Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer: current status and perspectives , 2004, International Journal of Clinical Oncology.
[5] H. von der Maase,et al. Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] H. von der Maase,et al. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. , 2004, International journal of radiation oncology, biology, physics.
[7] S. Shariat,et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens. , 2004, The Journal of urology.
[8] T. Wilt,et al. A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice? , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).
[9] L. Muren,et al. Treatment margins and treatment fractionation in conformal radiotherapy of muscle-invading urinary bladder cancer. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] B. Lind,et al. Dose to the anal sphincter region and risk of fecal leakage , 2004, Acta oncologica.
[11] Roberto Orecchia,et al. Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] A. Zietman,et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. , 2003, The Journal of urology.
[13] C. Vale. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis , 2003, The Lancet.
[14] H. Sandler,et al. Overview of bladder cancer trials in the Radiation Therapy Oncology Group , 2003, Cancer.
[15] Joos V Lebesque,et al. Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. , 2003, International journal of radiation oncology, biology, physics.
[16] D. Forman,et al. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. , 2003, European urology.
[17] M. Hulshof,et al. Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[18] H. von der Maase. Gemcitabine in transitional cell carcinoma of the urothelium , 2003, Expert review of anticancer therapy.
[19] J. Damber,et al. A Systematic Overview of Radiation Therapy Effects in Urinary Bladder Cancer , 2003, Acta oncologica.
[20] Riccardo Calandrino,et al. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy). , 2002, International journal of radiation oncology, biology, physics.
[21] J. Dunst,et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Franca Foppiano,et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] G. Steineck,et al. Distressful symptoms after radical radiotherapy for urinary bladder cancer. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] A. Murtha,et al. Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors. , 2001, International journal of radiation oncology, biology, physics.
[25] Michael Cookson,et al. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. , 2001, The Journal of urology.
[26] D P Dearnaley,et al. Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer. , 2001, International journal of radiation oncology, biology, physics.
[27] S. Groshen,et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] J F Fowler,et al. Biological Factors Influencing Optimum Fractionation in Radiation Therapy , 2001, Acta oncologica.
[29] S. Fosså,et al. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09. , 2000, International journal of radiation oncology, biology, physics.
[30] J. Cheville,et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. , 2000, American journal of clinical pathology.
[31] W. Mackillop,et al. A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. , 1999, International journal of radiation oncology, biology, physics.
[32] L. Kiemeney,et al. Epidemiology of Bladder Cancer , 1999, European Urology.
[33] D. Dearnaley,et al. Hypofractionated radiotherapy for patients with carcinoma of the bladder. , 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).
[34] Stott,et al. Contemporary results of radical radiotherapy for bladder transitional cell carcinoma in a district general hospital with cancer‐centre status , 1999, BJU international.
[35] A. Hart,et al. Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. , 1998, International journal of radiation oncology, biology, physics.
[36] J P Logue,et al. Clinical variability of target volume description in conformal radiotherapy planning. , 1998, International journal of radiation oncology, biology, physics.
[37] R. Buchanan,et al. An audit and evaluation of bladder movements during radical radiotherapy. , 1998, Clinical oncology (Royal College of Radiologists (Great Britain)).
[38] Chantal Ginestet,et al. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment , 1997 .
[39] R. Cowan,et al. Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. , 1997, International journal of radiation oncology, biology, physics.
[40] H. von der Maase,et al. Treatment outcome following radiotherapy in elderly patients with bladder cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[41] J. Wondergem,et al. Hypofractionated radiotherapy for invasive bladder cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[42] S. Johansson,et al. Long-term followup of a bladder carcinoma cohort: questionable value of radical radiotherapy. , 1997, The Journal of urology.
[43] M. Mason,et al. Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[44] J. Paradelo,et al. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study. , 1997, The Journal of urology.
[45] W P Mayles,et al. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[46] G. Fellin,et al. Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma: A survey by a self‐administered questionnaire , 1996, Cancer.
[47] F. Freiha,et al. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. , 1996, The Journal of urology.
[48] S. Holmäng,et al. Early complications and survival following short-term palliative radiotherapy in invasive bladder carcinoma. , 1996, The Journal of urology.
[49] W. De Neve,et al. Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[50] P. Carroll,et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. , 1995, International journal of radiation oncology, biology, physics.
[51] M. Stöckle,et al. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. , 1995, The Journal of urology.
[52] A. Pollack,et al. Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. , 1994, International journal of radiation oncology, biology, physics.
[53] I. Näslund,et al. Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial. , 1994, Acta oncologica.
[54] S. Fosså,et al. Bladder cancer definitive radiation therapy of muscle‐invasive bladder cancer: A retrospective analysis of 317 patients , 1993, Cancer.
[55] A. Tjønneland,et al. Survival of Danish cancer patients 1943-1987. Urinary tract. , 1993, APMIS. Supplementum.
[56] H. Storm,et al. Survival of Danish cancer patients, 1943-1987. , 1993, APMIS. Supplementum.
[57] W G Jones,et al. Changes in target volume during radiotherapy treatment of invasive bladder carcinoma. , 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).
[58] R. Fisher,et al. The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the prince of Wales hospital, Sydney, Australia , 1992, Cancer.
[59] E. Salminen. Unconventional fractionation for palliative radiotherapy of urinary bladder cancer. A retrospective review of 94 patients. , 1992, Acta oncologica.
[60] S. Fosså,et al. Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer. , 1992, Scandinavian journal of urology and nephrology.
[61] S. Jahnson,et al. Bladder carcinoma--a 20-year review of radical irradiation therapy. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[62] S Majewski,et al. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[63] M. Goitein,et al. Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.
[64] W. H. Kern,et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. , 1991, The Journal of urology.
[65] L. Akslen,et al. Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. , 1991, British journal of urology.
[66] P. Bassi,et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. , 1991, The Journal of urology.
[67] S. Fosså,et al. Short-term moderate-dose pelvic radiotherapy of advanced bladder carcinoma. A questionnaire-based evaluation of its symptomatic effect. , 1991, Acta oncologica.
[68] H. Barlebo,et al. Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group. , 1991, Scandinavian journal of urology and nephrology. Supplementum.
[69] D. Panicek,et al. Imaging of invasive bladder cancer. , 1990, Seminars in oncology.
[70] Abrahamsen Jf,et al. Long-term morbidity after curative radiotherapy for carcinoma of the bladder. A retrospective study. , 1990 .
[71] S. Davidson,et al. Assessment of factors influencing the outcome of radiotherapy for bladder cancer. , 1990, British journal of urology.
[72] L. Solin,et al. Prognostic factors in patients with bladder carcinoma treated with definitive irradiation , 1990, Cancer.
[73] E. Salminen. External beam radiation treatment of urinary bladder carcinoma. An analysis of results in 203 patients. , 1990, Acta oncologica.
[74] S. Fosså,et al. Long-term morbidity after curative radiotherapy for carcinoma of the bladder. A retrospective study. , 1990, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[75] J. Herman,et al. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. , 1989, The Journal of urology.
[76] E. Salminen. Split-course radiotherapy for urinary bladder cancer. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[77] P. Rubin,et al. Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group. , 1988, International journal of radiation oncology, biology, physics.
[78] H. Bloom,et al. Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report. , 1988, British journal of urology.
[79] C. Fowler,et al. Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. , 1988, British journal of urology.
[80] L. Solin,et al. Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing. , 1988, International journal of radiation oncology, biology, physics.
[81] A. Einstein,et al. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. , 1987, JAMA.
[82] W. Duncan,et al. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. , 1986, International journal of radiation oncology, biology, physics.
[83] D. Tolley,et al. Results of surgery following radical radiotherapy for invasive bladder cancer. , 1986, British journal of urology.
[84] W. Duncan,et al. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[85] B. Nilsson,et al. Irradiation therapy with multiple small fractions per day in urinary bladder cancer. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[86] W. Shipley,et al. Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. , 1985, The Journal of urology.
[87] J. Arndt,et al. [Results of radiotherapeutic optimization within the scope of combined operative-radiologic therapy of urinary bladder cancer]. , 1985, Zeitschrift fur Urologie und Nephrologie.
[88] J. Hanley,et al. Split‐course radiotherapy of carcinoma of the urinary bladder Stages C and D1: A Radiation Therapy Oncology Group study , 1985, American Journal of Clinical Oncology.
[89] H. Bloom,et al. Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. , 1982, British journal of urology.
[90] J. Elwood,et al. Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. , 1981, International journal of radiation oncology, biology, physics.
[91] R. Oliver,et al. T3 bladder cancer--the case for salvage cystectomy. , 1980, British journal of urology.
[92] L. Miller. Bladder cancer. Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C , 1977, Cancer.
[93] J. Fish,et al. Carcinoma of the urinary bladder. Influence of dose and volume irradiated on survival. , 1976, Radiology.
[94] D. Goffinet,et al. Bladder cancer: results of radiation therapy in 384 patients. , 1975, Radiology.
[95] W. Caldwell. Carcinoma of the urinary bladder. , 1974, JAMA.
[96] L. Miller,et al. Radiotherapy for carcinoma of the bladder. , 1966, The Journal of urology.